Published in Cancer Weekly, June 11th, 2002
Two researchers from the Institut Gustave-Roussy in France and the University of California (UC) Berkeley found that freezing cancer cells in test tubes made them far more vulnerable to attack by bleomycin, a potent anticancer drug also known by the brand name Blenoxane.
Cryosurgery - freezing cells to destroy them - and bleomycin are approved treatments currently used separately for cancer patients. But researchers of the study, published May 14, 2002, in the British Journal of Cancer, said that combining the two therapies may...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.